Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Baxter
Merck
McKesson
Boehringer Ingelheim

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tauroursodeoxycholic acid

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid is an investigational drug.

There have been 21 clinical trials for Tauroursodeoxycholic acid. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2012.

The most common disease conditions in clinical trials are Sclerosis, Motor Neuron Disease, and Amyotrophic Lateral Sclerosis. The leading clinical trial sponsors are Washington University School of Medicine, Children's Hospital Medical Center, Cincinnati, and Amylyx Pharmaceuticals Inc.

There are two hundred and sixty-eight US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Tauroursodeoxycholic acid
TitleSponsorPhase
Targeting ER Stress in Vascular DysfunctionColorado State UniversityEarly Phase 1
TUDCA as a Therapy for Ulcerative Colitis (UC)Crohn's and Colitis FoundationPhase 1
TUDCA as a Therapy for Ulcerative Colitis (UC)Washington University School of MedicinePhase 1

See all Tauroursodeoxycholic acid clinical trials

Clinical Trial Summary for Tauroursodeoxycholic acid

Top disease conditions for Tauroursodeoxycholic acid
Top clinical trial sponsors for Tauroursodeoxycholic acid

See all Tauroursodeoxycholic acid clinical trials

US Patents for Tauroursodeoxycholic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tauroursodeoxycholic acid   Start Trial Measurement method for human pancreatic lipase activity ASAHI KASEI PHARMA CORPORATION (Tokyo, JP)   Start Trial
Tauroursodeoxycholic acid   Start Trial 17-hydroxyprogesterone ester-containing oral compositions and related methods Lipocine Inc. (Salt Lake City, UT)   Start Trial
Tauroursodeoxycholic acid   Start Trial Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and use Vivus, Inc. (Campbell, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tauroursodeoxycholic acid

Drugname Country Document Number Estimated Expiration Related US Patent
Tauroursodeoxycholic acid China 105164273 2033-04-18   Start Trial
Tauroursodeoxycholic acid European Patent Office 2987867 2033-04-18   Start Trial
Tauroursodeoxycholic acid Spain 2654437 2033-04-18   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Dow
Johnson and Johnson
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.